NM_015192.4:c.2191C>G

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015192.4(PLCB1):​c.2191C>G​(p.Pro731Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 1,613,564 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0092 ( 23 hom., cov: 33)
Exomes š‘“: 0.0011 ( 14 hom. )

Consequence

PLCB1
NM_015192.4 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 1.28
Variant links:
Genes affected
PLCB1 (HGNC:15917): (phospholipase C beta 1) The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals. This gene is activated by two G-protein alpha subunits, alpha-q and alpha-11. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059148073).
BP6
Variant 20-8737175-C-G is Benign according to our data. Variant chr20-8737175-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 129904.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=4, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00917 (1396/152206) while in subpopulation AFR AF= 0.0311 (1292/41510). AF 95% confidence interval is 0.0297. There are 23 homozygotes in gnomad4. There are 681 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCB1NM_015192.4 linkc.2191C>G p.Pro731Ala missense_variant Exon 20 of 32 ENST00000338037.11 NP_056007.1 Q9NQ66-1
PLCB1NM_182734.3 linkc.2191C>G p.Pro731Ala missense_variant Exon 20 of 33 NP_877398.1 Q9NQ66-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCB1ENST00000338037.11 linkc.2191C>G p.Pro731Ala missense_variant Exon 20 of 32 1 NM_015192.4 ENSP00000338185.6 Q9NQ66-1

Frequencies

GnomAD3 genomes
AF:
0.00919
AC:
1398
AN:
152088
Hom.:
23
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0313
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00718
GnomAD3 exomes
AF:
0.00286
AC:
719
AN:
251204
Hom.:
13
AF XY:
0.00214
AC XY:
291
AN XY:
135752
show subpopulations
Gnomad AFR exome
AF:
0.0323
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.00884
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000654
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000150
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00107
AC:
1563
AN:
1461358
Hom.:
14
Cov.:
31
AF XY:
0.000924
AC XY:
672
AN XY:
726974
show subpopulations
Gnomad4 AFR exome
AF:
0.0299
Gnomad4 AMR exome
AF:
0.00237
Gnomad4 ASJ exome
AF:
0.00881
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000612
Gnomad4 OTH exome
AF:
0.00252
GnomAD4 genome
AF:
0.00917
AC:
1396
AN:
152206
Hom.:
23
Cov.:
33
AF XY:
0.00915
AC XY:
681
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.0311
Gnomad4 AMR
AF:
0.00360
Gnomad4 ASJ
AF:
0.00836
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00711
Alfa
AF:
0.00176
Hom.:
2
Bravo
AF:
0.0105
ESP6500AA
AF:
0.0261
AC:
115
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00336
AC:
408
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 03, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 32970752) -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

PLCB1: PP2, BP4, BS1, BS2 -

Sep 04, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Jun 11, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Early Infantile Epileptic Encephalopathy, Autosomal Recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Jun 21, 2016
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 12 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
20
DANN
Benign
0.97
DEOGEN2
Uncertain
0.69
.;.;.;D;.;T;.;T;T
Eigen
Benign
-0.0061
Eigen_PC
Benign
0.16
FATHMM_MKL
Benign
0.76
D
LIST_S2
Uncertain
0.91
D;D;.;D;D;D;D;D;D
MetaRNN
Benign
0.0059
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.2
.;.;M;M;M;.;.;.;.
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-3.8
.;.;D;D;D;.;.;.;D
REVEL
Benign
0.12
Sift
Benign
0.078
.;.;T;T;T;.;.;.;T
Sift4G
Benign
0.16
.;T;T;T;T;T;T;T;T
Polyphen
0.0010, 0.0
.;.;B;B;B;.;.;.;.
Vest4
0.12, 0.12, 0.13
MVP
0.51
MPC
1.1
ClinPred
0.033
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.18
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61755434; hg19: chr20-8717822; API